Company: CERO
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001213900-25-032134
Chunk: 2374

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 4
Chunk 2374
---
4 Equity Incentive Plan (the “2024 Plan”) and 2024 Employee Stock Purchase Plan (“2024 ESPP”),
with an initial reserve of 51,726 and 50,993 shares of common stock, respectively. The 2024 Plan and 2024 ESPP became effective on February
14, 2024 in connection with the closing of the Business Combination. At a special meeting of stockholders on April 30, 2024, the stockholders
approved an increase in the number of shares available for issuance under the 2024 Plan and the number of shares that may be issued pursuant
to incentive stock options, by an additional 20,000 shares each. At a special meeting of stockholders on November 11, 2024, the stockholders
approved an increase in the number of shares available for issuance under the 2024 Plan and the number of shares that may be issued pursuant
to incentive stock options, by an additional 208,454 shares each. As of December 31, 2024, no awards have been granted under the 2024
ESPP. The 2024 Plan has an evergreen provision that allows for an annual increase in the number of shares available for issuance under
the 2024 Plan to be added on the first day of January, starting with January 1, 2025, in an amount equal to the lesser of (i) 5% of the
fully diluted shares of our Common Stock on the immediately preceding December 31 or (ii) such number of shares as determined by our board
in each case subject to adjustment in the event of a stock split, stock dividend or other change in our capitalization. On January 1,
2025, the number of shares reserved under the 2024 Plan was increased by 5% of the fully diluted shares of our common stock on the immediately
preceding December 31, or 189,701 shares. The 2024 ESPP has an evergreen provision that allows for an annual increase in the number of
shares available for issuance under the 2024 ESPP to be added on the first day of each January, starting with January 1, 2025, by the
lesser of (i) 10,198 shares of our common stock, (ii) 1% of the fully diluted shares of common stock on the immediately preceding December
31, or (iii) such number of shares of common stock as determined by our board